Delivery Order SPE2DR25D1109-SPE2DR26FFH2G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,045.64 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count packaging) with an ultimate completion date of November 7, 2025. This non-competitive, firm fixed-price delivery order was issued on November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,596.69 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 36 mg on December 2, 2025, with completion scheduled for December 3, 2025. This contract represents a firm fixed-price delivery order under a non-competitive set-aside arrangement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36 mg tablets (100 count) on November 7, 2025, with a ceiling value of $2,593.37 and completion deadline of November 10, 2025. This competitively awarded contract utilizing firm fixed pricing represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,894.88 for Methylphenidate ER(LA) 20mg tablets (100 count) on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, with a ceiling value of $1,176.87 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued under the...
- The Defense Logistics Agency awarded a $1,514.42 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count packaging). This firm fixed-price delivery order, which is not set-aside, is set to be completed by November 14, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $2,855.75. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. The contract is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,647.48. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order valued at $4,123.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27mg (100 tablets) on December 8, 2025, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH2GDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,249.33 delivery order on December 2, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System and other government healthcare organizations. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for methylphenidate, a controlled substance used in the treatment of attention deficit hyperactivity disorder, aligns with the company's established role as a critical vendor for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/1/25 |